Additional information
Additional regional information :
- EU Member States (including overseas countries and territories linked to it (OCTs))
- Eligible non-EU countries : listed EEA countries and countries associated to the EU4Health Programme or countries which are in ongoing negotiations for an association agreement and where the agreement enters into force before the deadline for submission
Sectors :
All sectors Health Research & Innovation
Beneficiary :
All beneficiaries Association & NGO Local Authority & Affiliated Entity Research centre & university Training organisation & school
Regions :
Developing countries, European Economic Area, European Union
Category :
Call for proposals
Manager :
European Commission
Priorities and funded actions
Objective
To support Member States and relevant stakeholders to implement the results of recent and relevant research in relation to vaccination against COVID-19.
Priority
To deliver an inventory of relevant innovative public health research on COVID19 large-scale vaccination and implement plans in relevant Member States taking into account feasibility and country specific factors.
Among financed actions
- Mapping public health evidence and research results on COVID-19 large-scale vaccination that could be relevant for uptake, including findings, from Member States and outside of the Union
- Identifying challenges and assess the feasibility to implement solutions in Member States, based on the mapping and taking country-specific factors into account
- Developing implementation plans and pilot activities to respond to the current pandemic context or future health crises, or to optimise current routine vaccination practices, including catch-up vaccination
- Implementing the pilot activities in volunteering Member States including the activities identified as potentially most effective
Additional information
- This call for proposals is an open call for proposals
- Initial duration of the action: between 12 and 16 months
Eligibility
- Be legal entities (public or private bodies)
- Be established in one of the eligible countries
- Profound experience in the implementation of large-scale vaccination programmes